Calcium, Phosphate, and Vitamin D Supplementation in Osteopenia of Prematurity: Duration of Treatment
Continue calcium-phosphate and vitamin D supplementation until at least 12 months of postnatal age (or until bone density normalizes after the first year of life) in preterm infants with osteopenia of prematurity.
Evidence-Based Rationale
The most relevant guideline evidence indicates that preterm infants have decreased bone mineralization at birth, but after the first year of life, bone density normalizes 1. This provides the clearest endpoint for supplementation duration. Fractures associated with osteopenia of prematurity usually occur in the first year of life 1, establishing this as the critical risk period requiring active mineral supplementation.
Specific Supplementation Approach by Age
During Initial NICU Period (Birth to Discharge)
For growing premature infants on parenteral nutrition, provide:
- Calcium: 1.6-3.5 mmol/kg/day (64-140 mg/kg/day)
- Phosphorus: 1.6-3.5 mmol/kg/day (50-108 mg/kg/day)
- Magnesium: 0.2-0.3 mmol/kg/day (5.0-7.5 mg/kg/day) 2
After Transition to Full Enteral Feeding (0-6 months corrected age)
- Calcium: 0.8-1.5 mmol/kg/day (30-60 mg/kg/day)
- Phosphorus: 0.7-1.3 mmol/kg/day (20-40 mg/kg/day)
- Vitamin D: 400 IU/day minimum 2, 3
From 7-12 Months of Age
- Calcium: 0.5 mmol/kg/day (20 mg/kg/day)
- Phosphorus: 0.5 mmol/kg/day (15 mg/kg/day)
- Vitamin D: Continue at least 400 IU/day 2
Critical Monitoring Parameters
Regular monitoring is essential throughout the supplementation period 2:
- Serum alkaline phosphatase, calcium, phosphorus, and magnesium - check every 2 weeks initially, then monthly
- Urine calcium and phosphorus concentrations - monitor for hypercalciuria
- Radiographic bone assessment - obtain at diagnosis and periodically until normalization
- 25-hydroxyvitamin D levels - ensure adequacy without toxicity
The adequacy of calcium and phosphorus intakes can be confirmed when both minerals start being excreted simultaneously in urine with low concentrations (>1 mmol/L), indicating a slight surplus 2.
High-Risk Factors Requiring Extended Monitoring
Certain infants require particularly vigilant supplementation and may need continuation beyond 12 months:
- Gestational age <28 weeks or birth weight <1500g 1
- Prolonged parenteral nutrition (>4 weeks) 1, 4
- Bronchopulmonary dysplasia 1
- Extended diuretic or corticosteroid therapy 1
- Persistent biochemical abnormalities (elevated alkaline phosphatase >450 IU/L, low serum phosphorus) 5, 6
Common Pitfalls to Avoid
Do not stop supplementation prematurely at hospital discharge. Osteopenia commonly presents between 6-12 weeks of life 1, and fractures typically occur throughout the first year. The nutritional and mineral supplementation initiated in the NICU must be continued at home 1.
Avoid inadequate phosphorus provision. Recent evidence demonstrates that insufficient early phosphorus intake leads to hypophosphataemia, hypercalcaemia, and secondary hyperparathyroidism 5, 7, 6. A molar Ca:P ratio of 0.8-1.0 (rather than the traditional 1.3) may be more appropriate during early rapid growth phases 2.
Do not rely on vitamin D supplementation alone. While vitamin D at 400 IU/day is necessary 3, higher doses (900 IU/day vs 500 IU/day) show no additional benefit for bone mineralization in the first month 8. The primary issue is adequate calcium-phosphate delivery, not vitamin D deficiency 9, 6.
Endpoint for Discontinuation
Supplementation can be discontinued when:
- Infant reaches 12 months postnatal age (or corrected age in some protocols)
- Bone density has normalized (confirmed by radiography if obtained)
- Biochemical markers are stable (normal alkaline phosphatase, calcium, phosphorus)
- Infant is growing appropriately with adequate dietary calcium intake (>500 mg/day for children >12 months) 3
After the first year of life, bone density normalizes in preterm infants 1, and standard age-appropriate vitamin D supplementation (600 IU/day) can replace the intensive mineral supplementation protocol 3.